Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The NCT02778685 record is displayed instead of an access-denied page, providing details about the trial of pembrolizumab with endocrine therapy and palbociclib for metastatic breast cancer. The record includes study design and eligibility information, outcome measures, published research, and study documents.
    Difference
    81%
    Check dated 2026-11-11T01:22:31.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:35:54.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The page continues to display a 403 error instead of the study record.
    Difference
    1%
    Check dated 2026-10-20T23:25:53.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the study page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:09:28.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing detailed study information with a generic error view. This removes access to the trial's key data and related materials on the page.
    Difference
    23%
    Check dated 2026-09-22T23:40:22.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a new version of the page documentation.
    Difference
    0.0%
    Check dated 2026-09-15T23:43:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.